NEWS COMMENTARY

NHS to offer genetic tests to healthy British people on condition that they share their genetic data

Published:
January 28, 2019
Coverage:
Digital Transformation More...
Topics:
Activities:
Project More...
13275 thumb square
by Nardev Ramanathan
Very important

The NHS U.K. offers free genetic testing for the seriously ill as part of routine care. Now, the NHS will offer genetic tests to anyone, for a fee, with one condition – they must agree to share their anonymized data with the NHS. Having more population-level genomic data will deepen our understanding of human genetics not just in rare variants, but also in more common genetic variants that predispose people to diseases like diabetes. As the U.K. leads the way in genomic medicine, other countries are likely to follow its lead, particularly former British colonies. The lack of genomic data, particularly in Asia, presents significant market opportunities in diagnostics and data analytics that clients should look to exploit right away. 

For the original news article, click here .


Further Reading

Prototype cancer diagnostic wearable brings nothing new to the table

News Commentary | April 3, 2019

Not only does this technology not bring anything new to the table, but it is also not clear why a continuous blood draw is needed. While such solutions make sense for glucose monitoring in diabetes, where fluctuations could lead to life‑or‑death situations, there isn't a need to continuously draw ... Not part of subscription

Researchers use commercially available electronic nose technology to detect breast cancer

News Commentary | May 7, 2018

Researchers at Ben‑Gurion University reported that they could detect breast cancer using commercially available e‑nose technology that analyzes gases in women's breath. Using e‑noses for breath analysis is nothing new, and training the neural network using this data from early‑stage cancer patients ... Not part of subscription

An "arms race" is secretly brewing in Silicon Valley between consumer genomics players 23andMe and Helix Genomics

Analyst Insight | April 7, 2019

Background Both 23andMe and Helix Genomics made announcements just weeks apart from each other about their intentions to offer genomics services that provide insights into disease risks. 23andMe, arguably the largest consumer genomics company today, has already been marketing FDA‑approved ... Not part of subscription